Systemic/oral corticosteroids (OCS) have been used for decades in the management of
acute asthma exacerbations and chronically in patients with uncontrolled severe asthma …

The National Asthma Education and Prevention Program 1997 guidelines and 2002 update
provide an overview of potential local and systemic side effects associated with inhaled …

Objective Glucocorticoids (GCs) are often used to treat Rheumatoid Arthritis (RA) despite
their many side effects and the availability of other effective therapies. Cataract and …

The prevalence of posterior subcapsular cataracts in young patients receiving inhaled
glucocorticoids for treatment of chronic asthma is unknown. In a cross-sectional study, slit …

Prolonged exposure to inhaled corticosteroids among adults over 49 years old has been
reported to increase cataract risk. Small-scale studies of inhaled steroid users suggest that …

Background Intranasal budesonide is an efficacious treatment for perennial allergic rhinitis.
Long‐term effects on safety, particularly in children, need further investigation. Objective To …

Objectives. Psychiatric phenomena in asthma has been debated for some time. Inhaled
corticosteroids (ICS) are a significant part of treatment. We attempted to quantify the …

Purpose. Both systemic and inhaled corticosteroids may increase the risk of cataract in
patients with both chronic obstructive pulmonary disease (COPD) and asthma. Our aim was …

Inhaled corticosteroids (ICS) are the standard of care in asthma and are widely used in the
treatment of patients with chronic obstructive pulmonary disease. High-dose regimens and …

Inhaled corticosteroid (ICS) therapy carries less risk of complicating drug-or disease-related
morbidity and mortality than that associated with other antiasthmatic drugs such as …